CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)	3 Months Ended	6 Months Ended
Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenue
Total revenue	$ 123,004,546	$ 81,311,700	$ 247,171,273	$ 166,647,762
Expenses
Cost of services	99,464,892	66,672,236	184,135,500	126,214,808
General and administrative expenses	11,471,829	5,777,187	23,207,727	11,053,762
Depreciation and amortization	4,918,078	4,805,979	9,976,590	9,642,330
Total expenses	115,854,799	77,255,402	217,319,817	146,910,900
Income from operations	7,149,747	4,056,298	29,851,456	19,736,862
Other income (expense)
Income (loss) from equity method investments	1,669,861	(795,102)	1,641,837	1,432,160
Interest expense	(110,683)	(575)	(195,684)	(1,386)
Interest income	339,816	209,492	609,634	391,777
Change in fair value of derivative instruments	0	(1,394,443)	0	127,779
Other income	340,659	26,624	428,652	28,138
Total other income (expense), net	2,239,653	(1,954,004)	2,484,439	1,978,468
Income before provision for income taxes	9,389,400	2,102,294	32,335,895	21,715,330
Provision for income taxes	1,523,807	736,835	8,752,647	8,626,080
Net income	7,865,593	1,365,459	23,583,248	13,089,250
Net income (loss) attributable to noncontrolling interest	5,201,491	(629,284)	18,758,691	6,744,846
Net income attributable to Apollo Medical Holdings, Inc.	$ 2,664,102	$ 1,994,743	$ 4,824,557	$ 6,344,404
Earnings per share - basic	$ 0.08	$ 0.08	$ 0.15	$ 0.25
Earnings per share - diluted	$ 0.07	$ 0.07	$ 0.13	$ 0.22
Weighted average shares of common stock outstanding-basic	32,674,459	25,067,954	32,548,662	25,067,954
Weighted average shares of common stock outstanding - diluted	37,850,679	28,417,877	37,935,773	28,417,877
Capitation, net [Member]
Revenue
Revenue	$ 90,316,182	$ 62,879,587	$ 176,221,466	$ 127,595,720
Health Care, Other [Member]
Revenue
Revenue	13,866,217	8,358,598	31,852,953	19,495,798
Management Service [Member]
Revenue
Revenue	12,371,608	6,287,702	24,446,180	12,824,812
Health Care, Patient Service [Member]
Revenue
Revenue	5,679,469	3,044,548	13,427,578	5,708,461
Product and Service, Other [Member]
Revenue
Revenue	$ 771,070	$ 741,265	$ 1,223,096	$ 1,022,971

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.